Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Schizophrenia Spectrum & Other Psychotic Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT01924039
What this trial is testing

Brief Motivational Enhancement Therapy for Concurrent Disorders

Who this might be right for
PsychosisSubstance Use
Centre for Addiction and Mental Health 8
Early research (Phase 1)Study completedNCT00796471
What this trial is testing

A Pharmacokinetics and Pharmacodynamics Study Under Fasting and Fed Conditions With Paliperidone Extended-release and Immediate-release Formulations

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 35
Not applicableStudy completedNCT02642029
What this trial is testing

Targeting Cerebellum to Treat Psychosis: a Transcranial Magnetic Stimulation (TMS) Study

Who this might be right for
SchizophreniaSchizoaffective DisorderBipolar Disorder I
Mclean Hospital 28
Testing effectiveness (Phase 2)Temporarily pausedNCT05046353
What this trial is testing

D-serine AudRem: R33 Phase

Who this might be right for
SchizophreniaSchizo Affective Disorder
New York State Psychiatric Institute 60
Testing effectiveness (Phase 2)Study completedNCT01012167
What this trial is testing

Oxytocin or Galantamine Versus Placebo for the Treatment of Negative Symptoms and Cognitive Impairments in Schizophrenia

Who this might be right for
Schizophrenia
University of Maryland, Baltimore 86
Testing effectiveness (Phase 2)Looking for participantsNCT06887192
What this trial is testing

Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis

Who this might be right for
Psychosis Associated With Alzheimer's Disease
MapLight Therapeutics 300
Not applicableUnknownNCT04700930
What this trial is testing

CBD Cigarettes Instead of Normal Cigarettes as Innovative Treatment for Schizophrenia

Who this might be right for
Schizophrenia and Other Psychotic DisordersHarm Reduction
Psychiatric Hospital of the University of Basel 31
Large-scale testing (Phase 3)Study completedNCT00206128
What this trial is testing

Immediate Release (IR) to Sustained Release (SR) Switching Study: Study of Switching From IR Seroquel to SR Seroquel in Outpatients With Schizophrenia

Who this might be right for
Schizophrenia
AstraZeneca 454
Not applicableStudy completedNCT01729650
What this trial is testing

Effectiveness of a Physical Activity and Diet Program in Patients With Psychotic Disorder (CapiCor)

Who this might be right for
Schizophrenic DisordersSchizoaffective DisordersBipolar Disorders
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina 332
Not applicableStudy completedNCT03919760
What this trial is testing

Early Psychosis Intervention - Spreading Evidence-based Treatment

Who this might be right for
First Episode PsychosisSchizophrenia, ChildhoodPsychosis+7 more
Centre for Addiction and Mental Health 100
Not applicableUnknownNCT04123223
What this trial is testing

Comparing Cognitive Remediation Approaches for Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
Wesleyan University 135
Not applicableUnknownNCT03575442
What this trial is testing

"Art Therapy" in Acute Psychiatry

Who this might be right for
SchizophreniaMood DisordersMental Disorder+1 more
Unidade Local de Saúde de Coimbra, EPE 60
Testing effectiveness (Phase 2)Study completedNCT01934023
What this trial is testing

Effects of Varenicline on Plasticity in Schizophrenia

Who this might be right for
Schizophrenia
Centre for Addiction and Mental Health 24
Not applicableStudy completedNCT06807242
What this trial is testing

Implementation of a Tool for Reduction of Cardiovascular Risk in Patients with Severe Mental Disorders ( HEALTHYHEART )

Who this might be right for
Schizophrenic PsychosesSchizophreniaSevere Mental Disorder
Oslo University Hospital 270
Large-scale testing (Phase 3)Not Yet RecruitingNCT05946486
What this trial is testing

Evaluation of the Efficacy of Immunomodulatory Therapy in Case of Psychiatric Disorders With Proven Dysimmunity.

Who this might be right for
Mental Disorder
University Hospital, Bordeaux 174
Post-approval studies (Phase 4)UnknownNCT01742390
What this trial is testing

Study to Evaluate the Effects of Switching to Aripiprazole 12 Weeks on the Sexual Dysfunction From Risperidone or Paliperidone in Patients With Schizophrenia Spectrum Disorders or Bipolar Spectrum Disorders

Who this might be right for
Sexual DysfunctionHyperprolactinemia
Si Tianmei 120
Early research (Phase 1)Study completedNCT02174510
What this trial is testing

A Pharmacokinetic Study of Lurasidone After Single Oral Administration in Healthy Subjects

Who this might be right for
Schizophrenia
Marubeni Pharmaceuticals (Suzhou) Co., Ltd. 37
Not applicableStudy completedNCT01876524
What this trial is testing

TRNS in Anterior Cingulate Cortex Reduces Craving Over Dual Pathology Patients

Who this might be right for
Substance Use DisorderAttention Deficit Disorder With HyperactivityBipolar Disorder+2 more
Spanish Foundation for Neurometrics Development 225
Early research (Phase 1)Study completedNCT02087579
What this trial is testing

Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants

Who this might be right for
Psychotic DisordersSchizophreniaBipolar Disorder+1 more
Janssen Research & Development, LLC 305
Large-scale testing (Phase 3)Study completedNCT01626859
What this trial is testing

A Pharmacokinetic Study of MP-214 in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Tanabe Pharma Corporation 38
Next Page